Horizon scanning
Responding to the challenge of antimicrobial resistance
Antimicrobial resistance is a global emergency. The Government has set out a series of strategies to tackle it. What progress has been made?
-
-
Horizon scanning
Economic inequality and recovery
GDP and income inequality both influence population health. How might the COVID-19 outbreak widen economic inequalities in the long-term?
-
Horizon scanning
Regulation and state use of social media
The use of social media raises questions around security, state regulation, privacy, and online safety. How can states balance regulation and personal freedom?
-
Horizon scanning
Upskilling and retraining the adult workforce
Upskilling and retraining adults is key to addressing future challenges and benefits productivity, health and wellbeing, social justice and communities.
-
Horizon scanning
Use of digital technologies to tackle pandemics
Many innovations have improved the COVID-19 response and could be key for future-proofing against pandemics. What are the governance and privacy concerns?
-
Horizon scanning
Political polarisation and participation
Political polarisation could affect political participation. How do inequality and socioeconomic factors intersect with extremism?
-
Horizon scanning
The impact of early childhood education and care on children’s outcomes, and the sustainability of the sector
Early education and care can have positive and long-lasting impacts on children’s outcomes. What are the impact of changes in Government policy and COVID-19?
-
POSTnote
Living organ donation
This POSTnote describes the scale and nature of living donation in the UK, its regulatory framework and the ethical considerations around this highly regulated procedure. It also analyses challenges within living organ donation, and the strategies implemented to address them.
-
Rapid response
COVID-19 vaccine misinformation
There have been large volumes of inaccurate information about COVID-19 circulating since the beginning of the pandemic, including misinformation about vaccinations against the infection. This article looks at the types and sources of COVID-19 vaccine misinformation and its public health impact. It also looks at the different approaches being used to fight COVID-19 vaccine misinformation, such as social media content moderation and guidance for the public.
-
Rapid response
Which SARS-CoV-2 variants reduce the effectiveness of vaccines?
New SARS-CoV-2 variants identified around the world could have an impact on current vaccination programmes. What is the latest evidence on the effectiveness of the COVID-19 vaccines used in the UK on new variants? How quickly can these vaccines be updated and approved? What alternative strategies can be used?
-
POSTnote
Childhood Obesity
In 2019, the UK Government called childhood obesity “one of the biggest health challenges this country faces”. Childhood obesity contributes to a range of physical and mental health conditions. This POSTnote outlines current trends in childhood obesity, the impacts on children’s health and access to support. It also covers key risk factors for childhood obesity and evidence on the effectiveness of policies to address it.
-
Rapid response
COVID-19 vaccines and virus transmission
COVID-19 vaccines have been deployed in the UK since December 2020. This article examines the impact of COVID-19 vaccines on transmission of the virus. It also considers the potential implications of vaccine-induced protection for easing lockdown restrictions and debate about potential introduction of immunity certification or a vaccine passport scheme.
-
Rapid response
Latest evidence on impacts of COVID-19 in children: March 2021
How does COVID-19 affect children? Will children be vaccinated against the disease? This article summarises the latest findings from research and highlights where more research can explore some of the remaining uncertainties.
-
Rapid response
Changing the UK COVID-19 vaccine dosing schedule
On December 31, 2020 the four UK Chief Medical Officers (CMOs) published a statement announcing changes to the dosing schedule for the second dose of the Pfizer/BioNTech and University of Oxford/AstraZeneca vaccines. It stated that the interval between the first and second dose should be extended from 3–4 weeks to up to 12 weeks. This rapid response examines the evidence behind this decision.
-
Rapid response
COVID-19 in pregnant women and newborn babies
The body of research investigating the effects of Coronavirus infection on pregnancy is growing. What is the available evidence? How does COVID-19 affect pregnant women and their babies? Is the virus transmitted between mothers and babies? Are some women and babies at greater risk than others?
Total results (page 4 of 21)